The midbrain region periaqueductal grey (PAG) is rich in opioid receptors and endogenous opioids and is a major target of analgesic action in the central nervous system1. It has been proposed that the analgesic effect of opioids on the PAG works by suppressing the inhibitory influence of the neurotransmitter GABA (γ-aminobutyric acid) on neurons that form part of a descending antinociceptive pathway2. Opioids inhibit GABA-mediated (GABAergic) synaptic transmission in the PAG and other brain regions by reducing the probability of presynaptic neurotransmitter release3,4, but the mechanisms involved remain uncertain. Here we report that opioid inhibition of GABAergic synaptic currents in the PAG is controlled by a presynaptic voltage-dependent potassium conductance. Opioid receptors of the μ type in GABAergic presynaptic terminals are specifically coupled to this potassium conductance by a pathway involving phospholipase A2, arachidonic acid and 12-lipoxygenase. Furthermore, opioid inhibition of GABAergic synaptic transmission is potentiated by inhibitors of the enzymes cyclooxygenase and 5-lipoxygenase, presumably because more arachidonic acid is available for conversion to 12-lipoxygenase products. These mechanisms account for the analgesic action of cyclooxygenase inhibitors in the PAG5 and their synergism with opioids6.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Mansour, A., Fox, C. A., Akil, H. & Watson, S. J. Opioid-receptor mRNA expression in the rat CNS — anatomical and functional implications. Trends Neurosci. 18, 22–29 (1995).
Basbaum, A. I. & Fields, H. L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci. 7, 309–338 (1984).
Capogna, M., Gahwiler, B. H. & Thompson, S. M. Mechanism of μ-opioid receptor-mediated presynaptic inhibition in the rat hippocampus in vitro. J. Physiol. (Lond.) 470, 539–558 (1993).
Vaughan, C. W. & Christie, M. J. Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J. Physiol. (Lond.) 498, 463–472 (1997).
Tortorici, V. & Vanegus, H. Anti-nociception induced by systemic or PAG-microinjected lysine–acetylsalicylate in rats. Effects on tail-flick related activity of medullary off- and on-cells. Eur. J. Neurosci. 7, 1857–1865 (1995).
Maves, T. J., Pechman, P. S., Meller, S. T. & Gebhart, G. F. Ketorolac potentiates morphine antinociception during visceral nociception in the rat. Anesthesiology 80, 1094–1101 (1994).
North, R. A. Opioid actions on membrane ion channels.in Opioids (ed. Herz, A.) 773–798 (Springer, Berlin, (1993)).
Wimpey, T. & Chavkin, C. Opioids activate both an inward rectifier and a novel voltage-gated potassium conductance in the hippocampal formation. Neuron 6, 281–289 (1991).
Grissmer, S. et al. Pharmacological characterization of five cloned voltage gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol. Pharmacol. 45, 1227–1234 (1994).
Vaughan, C. W., Ingram, S. L. & Christie, M. J. Actions of the ORL1receptor ligand, nociceptin, on membrane properties of rat periaqueductal gray neurons in vitro. J. Neurosci. 17, 996–1003 (1997).
Simmons, M. L. & Chavkin, C. κ-Opioid receptor activation of a dendrotoxin-sensitive potassium channel mediates presynaptic inhibition of mossy fiber neurotransmitter release. Mol. Pharmacol. 50, 80–85 (1996).
Shapiro, M., Wollmuth, L. & Hille, B. Modulation of Ca2+ channels by PTX-sensitive G-proteins is blocked by N-ethylmaleimide in rat sympathetic neurons. J. Neurosci. 14, 7109–7116 (1994).
Capogna, M., Gahwiler, B. H. & Thompson, S. M. Presynaptic enhancement of inhibitory synaptic transmission in the rat hippocampus in vitro. J. Neurosci. 15, 1249–1260 (1995).
Fukuda, K., Kato, S., Morikawa, H., Shoda, T. & Mori, K. Functional coupling of the δ-, μ-, and κ-opioid receptors to mitogen-activated protein kinase and arachidonate release in chinese hamster ovary cells. J. Neurochem. 67, 1309–1316 (1996).
Blackwell, G. J. & Flower, R. J. Inhibition of phospholipase. Brit. Med. Bull. 39, 260–264 (1983).
Piomelli, D. & Greengard, P. Lipoxygenase metabolites of arachidonic acid in neuronal transmembrane signalling. Trends Pharmacol. Sci. 11, 367–373 (1990).
Duerson, K., White, R. E., Jiang, F., Schonbrunn, A. & Armstrong, D. L. Somatostatin stimulates BKCa channels in rat pituitary tumor cells through lipoxygenase metabolites of arachidonic acid. Neuropharmacology 35, 949–961 (1996).
Shimizu, T. & Wolfe, L. S. Arachidonic acid cascade and signal transduction. J. Neurochem. 55, 1–15 (1990).
Evans, J. F. et al. 5-Lipoxygenase-activating protein is the target of a quinole class of leukotriene synthesis inhibitors. Mol. Pharmacol. 40, 22–27 (1991).
Kurachi, Y. et al. α-Adrenergic activation of the muscarinic K+ channel is mediated by arachidonic acid metabolites. Pflugers Arch. 414, 102–104 (1989).
Schweitzer, P., Madamba, S. & Siggins, G. R. Arachidonic acid metabolites as mediators of somatostatin-induced increase of neuronal M-current. Nature 346, 464–467 (1990).
Piomelli, D. et al. Lipoxygenase metabolites of arachidonic acid as second messengers for presynaptic inhibition of Aplysia sensory cells. Nature 328, 38–43 (1987).
We thank J. P. Seale for reading the manuscript and K. Earle for help with the analysis. This work was supported by the NH and MRC of Australia and Human Frontiers in Science Program (S.L.I.).
About this article
Cite this article
Vaughan, C., Ingram, S., Connor, M. et al. How opioids inhibit GABA-mediated neurotransmission. Nature 390, 611–614 (1997). https://doi.org/10.1038/37610
This article is cited by
Tactile Stimulation in Adult Rats Modulates Dopaminergic Molecular Parameters in the Nucleus accumbens Preventing Amphetamine Relapse
Molecular Neurobiology (2022)
Brain Imaging and Behavior (2022)
The NOP Receptor System in Neurological and Psychiatric Disorders: Discrepancies, Peculiarities and Clinical Progress in Developing Targeted Therapies
CNS Drugs (2021)
Positive allosteric modulation of the cannabinoid type-1 receptor (CB1R) in periaqueductal gray (PAG) antagonizes anti-nociceptive and cellular effects of a mu-opioid receptor agonist in morphine-withdrawn rats